Begin main content

Call for Patient Input: Brineura

Published on: June 4, 2018
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.


Brand name Generic name Manufacturer Indication(s)
Brineura cerliponase alfa Biomarin Pharmaceutical (Canada) Inc. Neuronal Ceroid Lipofuscinosis Type 2
Project Number Call for patient input Patient input deadline Submit patient input
SR0574-000 2018-06-04 2018-07-24 Submit